Anders Alderborn
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism 2
-
- bioluminescence and chemiluminescence research 6
- Identification and Quantification in Food 2
- CRISPR and Genetic Engineering 2
- Genetics top 10%
- Virus-based gene therapy research 6
- Clinical Biochemistry top 10%
- Small Animals top 10%
-
- Cervical Cancer and HPV Research 3
-
- Animal Virus Infections Studies 3
-
- Animal Disease Management and Epidemiology 3
Anders Alderborn
27 papers receiving 846 citations
Peers
Comparison fields: 5 of 104
- Pharmacology 83
- Molecular Biology 495
- Genetics 189
- Clinical Biochemistry 37
- Small Animals 40
Countries citing papers authored by Anders Alderborn
This map shows the geographic impact of Anders Alderborn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Alderborn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Alderborn more than expected).
Fields of papers citing papers by Anders Alderborn
This network shows the impact of papers produced by Anders Alderborn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Alderborn. The network helps show where Anders Alderborn may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anders Alderborn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 98 | |
| 2 | 2009 | 14 | |
| 3 | 2005 | 50 | |
| 4 | 2004 | 4 | |
| 5 | 2004 | 21 | |
| 6 | 2003 | 44 | |
| 7 | 2003 | 32 | |
| 8 | 2002 | 48 | |
| 9 | 2002 | 15 | |
| 10 | 2002 | 12 | |
| 11 | 2001 | 12 | |
| 12 | 2001 | 26 | |
| 13 | 2000 | 209 | |
| 14 | 2000 | 5 | |
| 15 | 1997 | 4 | |
| 16 | 1996 | 10 | |
| 17 | 1994 | 3 | |
| 18 | 1992 | 6 | |
| 19 | 1992 | 15 | |
| 20 | Transcriptional activation of the human papillomavirus-16 P97 promoter by an 88-nucleotide enhancer containing distinct cell-dependent and AP-1-responsive modules. | 1990 | 78 |
About Anders Alderborn
Anders Alderborn is a scholar working on Agronomy and Crop Science, Animal Science and Zoology, Genetics, Internal Medicine and Molecular Biology, having authored 27 papers that have together received 895 indexed citations. Recurring topics across this work include Virus-based gene therapy research (6 papers), bioluminescence and chemiluminescence research (6 papers), Cervical Cancer and HPV Research (3 papers), Animal Virus Infections Studies (3 papers), Animal Disease Management and Epidemiology (3 papers), Identification and Quantification in Food (2 papers), Pharmacogenetics and Drug Metabolism (2 papers) and CRISPR and Genetic Engineering (2 papers). The work is most often cited by research in Pharmacology (83 citations), Molecular Biology (495 citations), Genetics (189 citations), Clinical Biochemistry (37 citations) and Small Animals (40 citations). Anders Alderborn has collaborated with scholars based in Sweden, United States and Switzerland. Frequent co-authors include Ulf Hammerling, M Pettersson, Maxine Allen, Erik Söderbäck, U. Pettersson, Lars Engstrand, Bertil Lindblom, H. Andréasson, Mia Wadelius and Jens G. Mattsson. Their work appears in journals such as Journal of Virology, Journal of Clinical Microbiology, BioTechniques, Helicobacter and Food and Chemical Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.